The Histone Deacetylase Inhibitor FK228 Increases Histone Acetylation, Coxsackie Adenovirus Receptor Levels and Adenovirus Transgene Expression in Human LOX IMVI Melanoma Xenografts

被引：0
作者：
Goldsmith, Merrill E. [1 ]
Steadman, Kenneth [1 ]
Aguila, Alian [1 ]
Alley, Michael C. [2 ]
Waud, William R. [3 ]
Bates, Susan [1 ]
Fojo, Tito [1 ]
机构：
[1] NCI, Med Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] NCI, Biol Testing Branch, Div Canc Treatment & Diag, NIH, Frederick, MD 21701 USA
[3] So Res Inst, Birmingham, AL 35255 USA
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.349
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
294
引用
收藏
页码：S112 / S112
页数：1
相关论文
共 41 条
  • [21] Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo
    Hiroki Sawa
    Hiromi Murakami
    Masaoki Kumagai
    Matsuyoshi Nakasato
    Shigeru Yamauchi
    Nozomu Matsuyama
    Yasuo Tamura
    Akira Satone
    Wataru Ide
    Ikuo Hashimoto
    Hajime Kamada
    [J]. Acta Neuropathologica, 2004, 107 : 523 - 531
  • [22] The HDAC Inhibitor FK228 Enhances Adenoviral Transgene Expression by a Transduction-Independent Mechanism but Does Not Increase Adenovirus Replication
    Danielsson, Angelika
    Dzojic, Helena
    Rashkova, Victoria
    Cheng, Wing-Shing
    Essand, Magnus
    [J]. PLOS ONE, 2011, 6 (02):
  • [23] Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo
    Sasakawa, Y
    Naoe, Y
    Inoue, T
    Sasakawa, T
    Matsuo, M
    Manda, T
    Mutoh, S
    [J]. BIOCHEMICAL PHARMACOLOGY, 2002, 64 (07) : 1079 - 1090
  • [24] Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo
    Sawa, H
    Murakami, H
    Kumagai, M
    Nakasato, M
    Yamauchi, S
    Matsuyama, N
    Tamura, Y
    Satone, A
    Ide, W
    Hashimoto, I
    Kamada, H
    [J]. ACTA NEUROPATHOLOGICA, 2004, 107 (06) : 523 - 531
  • [25] The histone deacetylase inhibitor FK228 distinctly sensitizes the human leukemia cells to retinoic acid-induced differentiation
    Savickiene, Jurate
    Treigyte, Grazina
    Borutinskaite, Veronika
    Navakauskiene, Ruta
    Magnusson, Karl-Eric
    [J]. SIGNAL TRANSDUCTION PATHWAYS, PT B: STRESS SIGNALING AND TRANSCRIPTIONAL CONTROL, 2006, 1091 : 368 - 384
  • [26] Histone deacetylase inhibition up-regulates CAR and increases adenovirus infection and transgene expression in skeletal muscle
    Brooks, AR
    Cashion, L
    Reiter, K
    Wang, PY
    Qian, HS
    Harkins, RN
    Rubanyi, GM
    [J]. MOLECULAR THERAPY, 2004, 9 : S300 - S300
  • [27] The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy
    Karam, Jose A.
    Fan, Jinhai
    Stanfield, Jennifer
    Richer, Edmond
    Benaim, Elie A.
    Frenkel, Eugene
    Antich, Peter
    Sagalowsky, Arthur I.
    Mason, Ralph P.
    Hsieh, Jer-Tsong
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (08) : 1795 - 1802
  • [28] Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and Replication
    Saha, Bratati
    Parks, Robin J.
    [J]. JOURNAL OF VIROLOGY, 2019, 93 (12)
  • [29] In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD/Shi-scid/scid mice
    Kosugi, H
    Ito, M
    Yamamoto, Y
    Towatari, M
    Ito, M
    Ueda, R
    Saito, H
    Naoe, T
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (05): : 529 - 536
  • [30] Identification of cytochrome P450 enzymes involved in the metabolism of FK228, a potent histone deacetylase inhibitor, in human liver microsomes
    Shiraga, T
    Tozuka, Z
    Ishimura, R
    Kawamura, A
    Kagayama, A
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (01) : 124 - 129
12345